1242241-66-2

Basic information

• Product Name: 4',7-di-O-benzyldaidzein 8-C-β-D-(2,3,4,6-tetra-O-benzylglucoside)
• Synonyms: 4',7-di-O-benzyldaidzein 8-C-β-D-(2,3,4,6-tetra-O-benzylglucoside)
• CAS NO: 1242241-66-2
• Molecular Weight: 957.132
• Mol File: 1242241-66-2.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 4',7-di-O-benzyldaidzein 8-C-β-D-(2,3,4,6-tetra-O-benzylglucoside)(CAS DataBase Reference)
• NIST Chemistry Reference: 4',7-di-O-benzyldaidzein 8-C-β-D-(2,3,4,6-tetra-O-benzylglucoside)(1242241-66-2)
• EPA Substance Registry System: 4',7-di-O-benzyldaidzein 8-C-β-D-(2,3,4,6-tetra-O-benzylglucoside)(1242241-66-2)

Safety Data

• Hazardous Substances Data: 1242241-66-2(Hazardous Substances Data)

Downstream Products

• 3681-99-0 puerarin 

Relevant articles and documents

Glucose uptake enhancing activity of puerarin and the role of C-glucoside suggested from activity of related compounds

Chemical treatment of diabetes mellitus is widely studied and controlling of blood glucose level is the main course of therapy. In type 2 diabetes mellitus, insulin resistance is the major problem. An isoflavone C-glucoside, puerarin (1), is known to enhance glucose uptake into the insulin sensitive cell and is thought to be a candidate for treatment of diabetes mellitus. We synthesized 1 and several derivatives to apply for the structure-activity relationship study. The result against 3T3-L1 adipocyte indicated that the C-glucoside part of 1 is unconcerned in its activity when tested in vitro and the main structure responsible for its activity was the isoflavone moiety.